CENBIMO S.L

CENBIMO S.L is a pioneering company at the cutting edge of healthcare diagnostics.

Established in 2004, CENBIMO S.L with its team of dedicated scientists has patented a new technique using molecular biology technology to create novel single stranded DNA probes for the detection of gene expression by in situ hybridization.

With this technology CENBIMO S.L has developed the HistoSonda® , a powerful new generation of CISH probes ready for diagnostic use alongside routine immunohistochemistry.

Our advanced probes simplify the technique of in situ hybridization to a process that can be performed in any standard immunohistochemisty laboratory.

Although primarily designed and developed for healthcare diagnostics, the HistoSonda® also have important applications in veterinary and research fields.

CENBIMO S.L has always centred its efforts on investigation, development and innovation.

We hold the ISO 9001:2000 & ISO 13485 general certificate of quality and are certified by AENOR as a project of Investigation, Development and innovation (I+D+i).

All of our products carry the CE Mark of conformity and comply with the necessary requisites for their fabrication and commercialization.

CENBIMO S.L headquarters are located in Lugo, Spain. We are a rapidly expanding company, continuously evolving, refining and developing our products with a commitment to contributing real advances to the field of healthcare diagnostics.